A Fast-Moving Inherited Macular Dystrophy
Beneath the retina sits a thin membrane called Bruch's membrane, acting rather like a filter between the retina and its blood supply. In Sorsby fundus dystrophy, a faulty protein thickens that filter abnormally, and the retina responds by growing fragile new blood vessels to try to compensate — vessels that leak and bleed easily. It is this neovascular response, arriving decades earlier than it typically would with ordinary age-related disease, that makes Sorsby dystrophy one of the more aggressive conditions in this entire category.
For a Nigerian patient in their thirties or forties whose vision has dropped sharply over a matter of weeks rather than years, that pace itself is often the clue that points toward Sorsby rather than a more slowly progressing dystrophy.
Unlike most inherited macular conditions, Sorsby dystrophy can produce genuinely sudden or rapid central vision loss in one eye, with the second eye typically following within a few years. Distortion of straight lines and a rapidly enlarging blurred patch in central vision are common presenting complaints, and a subtle difficulty adjusting to dim light sometimes precedes the more dramatic central symptoms by months or even years.
Mutations in the TIMP3 gene are responsible, disrupting a protein normally involved in regulating tissue remodelling around Bruch's membrane. The membrane thickens as a result, and abnormal, leaky blood vessels then grow beneath the retina in response — a process called choroidal neovascularisation. Inheritance is autosomal dominant, meaning a single faulty copy from either parent is enough to cause the condition.
A fundus examination often reveals distinctive yellow-white deposits along the retinal blood vessel arcades, a pattern experienced examiners learn to recognise quickly. OCT and OCT-angiography, or fluorescein angiography where needed, are used to detect and map any active neovascular membrane, since finding one changes the urgency of the situation considerably. Genetic testing for TIMP3 confirms the diagnosis, and given how quickly this condition can move, testing is arranged without unnecessary delay.
Because active neovascular membranes can worsen quickly, addressing that complication is always the immediate priority once found, managed alongside our broader retinal evaluation. Once the eye has been stabilised, regenerative stem cell therapy is considered as part of a supportive plan for eligible patients, with a monitoring schedule set noticeably closer than for slower-progressing dystrophies, given how aggressively this particular condition can move.
Yes, and this rapid pace is actually one of the defining features of Sorsby fundus dystrophy, setting it apart from most other inherited macular conditions that progress far more gradually. It's exactly this speed that makes prompt evaluation so important here.
It can be, since both involve abnormal new blood vessel growth beneath the retina and can look similar on a scan. The age of onset, the family history, and genetic testing for TIMP3 are what ultimately distinguish Sorsby dystrophy from the age-related form.
Finding an active neovascular membrane does raise the urgency of the situation, since these vessels can cause further rapid vision loss if left unaddressed. We prioritise stabilising that specific complication before moving on to the broader retinal plan.
Not definitely, but the risk is meaningful, since Sorsby dystrophy is inherited in an autosomal dominant pattern, giving each child of an affected parent roughly a fifty percent chance of inheriting the faulty gene. Severity can still vary between family members, and genetic testing can offer a more precise picture for your own family.